The global oncology-based molecular diagnostics market is set for steady growth, with its valuation rising from USD 3.66 billion in 2024 to USD 6.12 billion by 2034, expanding at a CAGR of 5.3% over the forecast period (2025–2034). Increasing demand for personalized oncology testing, growing cancer prevalence, and rapid advancements...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek